Post by
Charts1 on Apr 30, 2021 1:45pm
CANN.V THEY ARE IN US MARKETS
(CSE: CANN) (OTCQX: HERTF) (“Heritage” or the “Company”), is pleased to announce that, through a phased approach in 2021, the Company will be launching several new medical products formulated with the patented VESIsorb® delivery system technology in the U.S. through its subsidiary Opticann, including ArthroCBD softgel capsules as well as topical cannabinoid applications that have been formulated to address some of the most pressing consumer health concerns, such as eczema, psoriasis, and local pain.